179 related articles for article (PubMed ID: 10051623)
21. Identification of the Syk kinase inhibitor R112 by a human mast cell screen.
Rossi AB; Herlaar E; Braselmann S; Huynh S; Taylor V; Frances R; Issakani SD; Argade A; Singh R; Payan DG; Masuda ES
J Allergy Clin Immunol; 2006 Sep; 118(3):749-55. PubMed ID: 16950297
[TBL] [Abstract][Full Text] [Related]
22. Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.
Yamadori T; Baba Y; Matsushita M; Hashimoto S; Kurosaki M; Kurosaki T; Kishimoto T; Tsukada S
Proc Natl Acad Sci U S A; 1999 May; 96(11):6341-6. PubMed ID: 10339589
[TBL] [Abstract][Full Text] [Related]
23. Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide].
Mahajan S; Ghosh S; Sudbeck EA; Zheng Y; Downs S; Hupke M; Uckun FM
J Biol Chem; 1999 Apr; 274(14):9587-99. PubMed ID: 10092645
[TBL] [Abstract][Full Text] [Related]
24. Btk Inhibitor RN983 Delivered by Dry Powder Nose-only Aerosol Inhalation Inhibits Bronchoconstriction and Pulmonary Inflammation in the Ovalbumin Allergic Mouse Model of Asthma.
Phillips JE; Renteria L; Burns L; Harris P; Peng R; Bauer CM; Laine D; Stevenson CS
J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):233-41. PubMed ID: 27111445
[TBL] [Abstract][Full Text] [Related]
25. Modulation of the Fcepsilon receptor I signaling by tyrosine kinase inhibitors: search for therapeutic targets of inflammatory and allergy diseases.
Lusková P; Dráber P
Curr Pharm Des; 2004; 10(15):1727-37. PubMed ID: 15180535
[TBL] [Abstract][Full Text] [Related]
26. Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells.
Ishizuka T; Chayama K; Takeda K; Hamelmann E; Terada N; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1999 Feb; 162(4):2087-94. PubMed ID: 9973482
[TBL] [Abstract][Full Text] [Related]
27. Activation loop phosphorylation modulates Bruton's tyrosine kinase (Btk) kinase domain activity.
Lin L; Czerwinski R; Kelleher K; Siegel MM; Wu P; Kriz R; Aulabaugh A; Stahl M
Biochemistry; 2009 Mar; 48(9):2021-32. PubMed ID: 19206206
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of a molecule, BAM11, that associates with the pleckstrin homology domain of mouse Btk.
Kikuchi Y; Hirano M; Seto M; Takatsu K
Int Immunol; 2000 Oct; 12(10):1397-408. PubMed ID: 11007757
[TBL] [Abstract][Full Text] [Related]
29. Production of monoclonal antibodies to Bruton's tyrosine kinase.
Stewart DM; Kurman CC; Nelson DL
Hybridoma; 1995 Jun; 14(3):243-6. PubMed ID: 7590786
[TBL] [Abstract][Full Text] [Related]
30. Bruton's tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse.
Dingjan GM; Middendorp S; Dahlenborg K; Maas A; Grosveld F; Hendriks RW
J Exp Med; 2001 May; 193(10):1169-78. PubMed ID: 11369788
[TBL] [Abstract][Full Text] [Related]
31. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.
Anderson JS; Teutsch M; Dong Z; Wortis HH
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10966-71. PubMed ID: 8855292
[TBL] [Abstract][Full Text] [Related]
32. Increased secretion of TNF-alpha by costimulation of mast cells via CD28 and Fc epsilon RI.
Tashiro M; Kawakami Y; Abe R; Han W; Hata D; Sugie K; Yao L; Kawakami T
J Immunol; 1997 Mar; 158(5):2382-9. PubMed ID: 9036988
[TBL] [Abstract][Full Text] [Related]
33. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement.
Yang W; Desiderio S
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):604-9. PubMed ID: 9012831
[TBL] [Abstract][Full Text] [Related]
34. Defective B cell development and function in Btk-deficient mice.
Khan WN; Alt FW; Gerstein RM; Malynn BA; Larsson I; Rathbun G; Davidson L; Müller S; Kantor AB; Herzenberg LA
Immunity; 1995 Sep; 3(3):283-99. PubMed ID: 7552994
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic potential of inhibiting Bruton's tyrosine kinase, (BTK).
Vassilev AO; Uckun FM
Curr Pharm Des; 2004; 10(15):1757-66. PubMed ID: 15180538
[TBL] [Abstract][Full Text] [Related]
36. Btk-dependent Rac activation and actin rearrangement following FcepsilonRI aggregation promotes enhanced chemotactic responses of mast cells.
Kuehn HS; Rådinger M; Brown JM; Ali K; Vanhaesebroeck B; Beaven MA; Metcalfe DD; Gilfillan AM
J Cell Sci; 2010 Aug; 123(Pt 15):2576-85. PubMed ID: 20587594
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
38. Nonreceptor tyrosine kinases ITK and BTK negatively regulate mast cell proinflammatory responses to lipopolysaccharide.
Huang W; Morales JL; Gazivoda VP; August A
J Allergy Clin Immunol; 2016 Apr; 137(4):1197-1205. PubMed ID: 26581914
[TBL] [Abstract][Full Text] [Related]
39. Ability of Bruton's Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling.
Bender AT; Gardberg A; Pereira A; Johnson T; Wu Y; Grenningloh R; Head J; Morandi F; Haselmayer P; Liu-Bujalski L
Mol Pharmacol; 2017 Mar; 91(3):208-219. PubMed ID: 28062735
[TBL] [Abstract][Full Text] [Related]
40. Activation of multiple protein kinases including a MAP kinase upon Fc epsilon RI cross-linking.
Fukamachi H; Takei M; Kawakami T
Int Arch Allergy Immunol; 1993; 102(1):15-25. PubMed ID: 8400883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
